Arkolith/Insider Trading/COGT/Form 4

Fairmount Funds Management LLC

DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$127.4M
Net Open-Market Flow
-$127.4M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Sell(S)3.5M$36.40$127.4M5.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-005924) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML